Wilson Karen J's Form 4 filing
Serina Therapeutics, Inc. (SER) · filed Jun 15, 2026
- Accession no.
- 0001267490-26-000006
- Filed
- Jun 15, 2026
- Trade date
- Jun 11-12, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $17.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wilson Karen JCIK 0001267490 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | PPurchaseAcquired | +5,100 | $1.75 | +$8,925 | 5,100 | Direct | |
| Jun 12, 2026 | Common Stock | PPurchaseAcquired | +5,000 | $1.77 | +$8,850 | 10,100 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.